Tenofovir: a nucleotide analogue reverse-transcriptase inhibitor for treatment of HIV infection.
DeChristoforo
Robert
R
Pharmacy Department, National Institutes of Health, Building 10, Room 1N-257 MSC-1196, 10 Center Drive, Bethesda, MD 20892-1196, USA. rdechristo@nih.gov
Penzak
Scott R
SR
D000225:Adenine / Q000031:analogs & derivatives*; D000368:Aged; D002648:Child; D002986:Clinical Trials as Topic; D003376:Counseling; D004496:Education, Continuing; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D018894:Reverse Transcriptase Inhibitors; D012449:Safety; D000068698:Tenofovir; D016896:Treatment Outcome; D014481:United States
D063065:Organophosphonates; D009943:Organophosphorus Compounds; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine